Skip to article
Astra

Sleep Medicine

Obstructive Sleep Apnea

Diagnose suspected obstructive sleep apnea with appropriate sleep testing, prioritize symptom relief and blood-pressure control, and match PAP, mandibular advancement, weight management, positional therapy, or selected surgery to anatomy, severity, and treatment tolerance.

Clinical question: How should physicians confirm and individualize treatment for adult obstructive sleep apnea while addressing cardiometabolic and perioperative risk?

Diagnosis

Confirm OSA with sleep testing before selecting therapy

Testing should establish the sleep-breathing disorder and provide a baseline for treatment response.

Order diagnostic sleep testing when the history and examination raise concern for clinically important OSA; the American Academy of Sleep Medicine diagnostic guideline addresses testing strategy for adults. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ... In patients with cardiovascular disease or hypertension, identify OSA as a potential contributor to elevated blood pressure and symptom burden, but do not treat a screening result as a diagnostic endpoint. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...jacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ...

Use the diagnostic study to distinguish obstructive events from other sleep-disordered breathing patterns before choosing PAP mode, oral appliance therapy, or an upper-airway intervention. Reassess for alternative explanations of daytime sleepiness, impaired function, or nocturnal symptoms when sleep testing does not establish clinically relevant OSA. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...jacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ...

Document blood pressure, body weight, sleepiness-related functional risk, and cardiovascular comorbidity at diagnosis because these parameters affect treatment goals. Moderate-to-severe OSA is associated with hypertension, cardiovascular events, and mortality; severe OSA is also associated with increased all-cause mortality. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...jacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ...

Clinical features that change the diagnostic and management objective in OSA. The LancetAdult obstructive sleep apnoeaBMJEffects of obstructive sleep apnoea risk on postoperative ...AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...jacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ...
Clinical contextDecision implicationImmediate next step
Excessive sleepiness with driving or work-safety exposureFocus treatment on symptom control and accident-risk reduction; OSA is associated with road traffic accidents. The LancetAdult obstructive sleep apnoeaExpedite diagnostic sleep evaluation and address safety-sensitive activities pending effective treatment. The LancetAdult obstructive sleep apnoea
Resistant hypertensionOSA may contribute to blood-pressure elevation; CPAP can reduce BP in some patients with resistant hypertension. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...Confirm OSA, continue guideline-directed antihypertensive therapy, and assess PAP use and BP response. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...
Established cardiovascular disease without prominent sleepinessPAP may improve OSA-related symptoms and BP, but randomized trials have not shown prevention of cardiovascular events or mortality. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...jacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ...Set treatment goals around OSA control, symptoms, quality of life, and BP rather than promising event reduction. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...jacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ...
Upcoming surgery or postoperative hypoxemia riskOSA risk is relevant to perioperative respiratory complications. BMJEffects of obstructive sleep apnoea risk on postoperative ...Flag OSA risk for anesthesia and postoperative monitoring planning. BMJEffects of obstructive sleep apnoea risk on postoperative ...

Initial Treatment

Use PAP as the principal noninvasive treatment and measure adherence

Therapy should target airway obstruction, symptoms, functional impairment, and relevant blood-pressure burden.

Offer positive airway pressure therapy as the principal noninvasive treatment for diagnosed OSA when the patient can use it. PAP effectively treats OSA, while CPAP can eliminate recurrent hypoxia and reduce nocturnal blood pressure and heart rate. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...AHA JournalsSleep Apnea and Cardiovascular Disease | Circulation At initiation, establish a practical adherence plan that addresses mask tolerance, nasal symptoms, pressure comfort, sleep schedule, and device-download review.

At follow-up, assess patient-reported sleepiness, functional improvement, adverse effects, residual device-reported events, and actual nightly use rather than assuming efficacy from prescription alone. The association between hours of CPAP use and improved insulin sensitivity in randomized data supports prioritizing sustained nightly exposure when metabolic outcomes are relevant. jaccSleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences

For hypertension, continue antihypertensive medication rather than substituting CPAP for standard blood-pressure treatment. Weight loss combined with CPAP can reduce BP in adults with overweight or obesity, and some studies show BP reduction with CPAP in resistant hypertension. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ... Do not represent CPAP as established secondary prevention for cardiovascular events: randomized comparisons of CPAP with usual care have not shown reductions in mortality, cardiovascular events, or kidney events. jacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ...

Outcome-directed follow-up after PAP initiation. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...jaccSleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequencesjacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ...
Follow-up domainWhat to reviewHow it changes management
OSA controlPAP tolerance and device-use information. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...jaccSleep Apnea: Types, Mechanisms, and Clinical Cardiovascular ConsequencesTroubleshoot interface, pressure comfort, and sleep schedule when effective use is limited. NatureThe association between irregularity in sleep-wake rhythm and CPAP adherence | npj Biological Timing and SleepjaccSleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences
Symptoms and functionDaytime sleepiness, quality of life, and safety-sensitive impairment. The LancetAdult obstructive sleep apnoeajacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ...Continue or modify therapy based on clinically meaningful functional response. The LancetAdult obstructive sleep apnoeajacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ...
Blood pressureOffice or out-of-office BP trend, particularly in resistant hypertension. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...Maintain antihypertensive therapy; use PAP and weight loss as adjunctive BP strategies. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...
Cardiovascular preventionPatient expectations regarding myocardial infarction, stroke, and mortality. jacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ...jaccSleep Disordered Breathing and Cardiovascular Disease: JACC State-of-the-Art ReviewDo not promise event or mortality reduction from CPAP based on current randomized evidence. jacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ...

Cardiometabolic expectations

Explain the treatment target precisely: CPAP improves OSA control and may improve blood pressure, insulin sensitivity, symptoms, and quality of life, but evidence does not establish that CPAP prevents cardiovascular events in unselected cardiovascular populations. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...jaccSleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequencesjacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ...jaccSleep Disordered Breathing and Cardiovascular Disease: JACC State-of-the-Art Review This distinction is especially important when an asymptomatic patient is considering treatment primarily for cardiovascular risk reduction.

Therapy Selection

Match alternatives to PAP intolerance, patient preference, anatomy, and severity

Non-PAP therapy is appropriate when it can provide an effective and durable alternative for the individual patient.

Offer a mandibular advancement device to adults with OSA who prefer oral-appliance therapy or cannot tolerate CPAP. ACP recommends mandibular advancement devices as an alternative to CPAP in diagnosed OSA, and professional guidance supports oral appliances for patients who prefer them or are CPAP-intolerant. acpjournalsManagement of Obstructive Sleep Apnea in AdultsScienceDirectPrediction of oral appliance treatment outcomes in obstructive sleep apnea: A systematic review - ScienceDirect Custom devices fitted by a qualified dentist outperform off-the-shelf appliances and should be physician-prescribed. AHA JournalsObstructive Sleep Apnea and Cardiovascular Disease

Mandibular advancement devices are most commonly used for mild-to-moderate OSA or when CPAP is not tolerated, although response is not uniform across severity categories. AHA JournalsObstructive Sleep Apnea and Cardiovascular DiseaseScienceDirectPrediction of oral appliance treatment outcomes in obstructive sleep apnea: A systematic review - ScienceDirect Reassess symptoms and objective treatment response after device titration; do not infer control from perceived snoring reduction alone. Oral appliances can cause myofascial discomfort and excess salivation, which should prompt dental adjustment rather than automatic discontinuation. AHA JournalsObstructive Sleep Apnea and Cardiovascular Disease

Use positional therapy when testing and clinical pattern suggest positional OSA and when a positional strategy is acceptable to the patient. Positional OSA occurs even in severe disease, and lateral-position approaches may be particularly relevant when obstruction is tongue-base predominant. BMJConfidential: For Review OnlyBMJ1 / 94 1 May 13th, 2025 2 Dr. Di Wang 3 Clinical Editor, The ... Confirm that the intervention controls the patient’s documented sleep-disordered breathing burden rather than relying solely on subjective improvement.

Recommend weight management for adults with overweight or obesity as a disease-modifying adjunct to airway therapy. Weight loss and lifestyle interventions improve OSA severity, and weight loss combined with CPAP can reduce BP. NaturePathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome | Signal Transduction and Targeted TherapyAHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...jaccSleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences Bariatric surgery is among available OSA treatment approaches for selected patients with obesity, but it should not be presented as a guaranteed cure of OSA. NaturePathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome | Signal Transduction and Targeted TherapyAHA JournalsObstructive Sleep Apnea and Cardiovascular Disease

Selection of non-PAP OSA therapies. NaturePathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome | Signal Transduction and Targeted TherapyacpjournalsManagement of Obstructive Sleep Apnea in AdultsAHA JournalsObstructive Sleep Apnea and Cardiovascular DiseasejaccSleep Apnea and Cardiovascular DiseaseScienceDirectPrediction of oral appliance treatment outcomes in obstructive sleep apnea: A systematic review - ScienceDirectScienceDirectContinuous positive airway pressure versus mandibular advancement device in the treatment of obstructive sleep apnea: a systematic review and meta-analysis - ScienceDirect
OptionBest-supported roleKey tradeoff or monitoring need
Custom mandibular advancement deviceAlternative for diagnosed OSA when the patient prefers it or cannot tolerate CPAP; commonly used for mild-to-moderate OSA. acpjournalsManagement of Obstructive Sleep Apnea in AdultsAHA JournalsObstructive Sleep Apnea and Cardiovascular DiseaseScienceDirectPrediction of oral appliance treatment outcomes in obstructive sleep apnea: A systematic review - ScienceDirectRequires physician prescription and qualified dental fitting; monitor for myofascial discomfort and salivation. AHA JournalsObstructive Sleep Apnea and Cardiovascular Disease
Positional therapyConsider when testing identifies positional OSA or anatomy suggests position-responsive tongue-base obstruction. BMJConfidential: For Review OnlyBMJ1 / 94 1 May 13th, 2025 2 Dr. Di Wang 3 Clinical Editor, The ...Verify clinical and objective response because positional dependence can occur even in severe OSA. BMJConfidential: For Review Only
Weight managementAdjunct for OSA in overweight or obesity; may improve OSA severity and BP when combined with CPAP. NaturePathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome | Signal Transduction and Targeted TherapyAHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...jaccSleep Apnea: Types, Mechanisms, and Clinical Cardiovascular ConsequencesDoes not replace reassessment of residual OSA or PAP/oral-appliance need. NaturePathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome | Signal Transduction and Targeted TherapyAHA JournalsObstructive Sleep Apnea and Cardiovascular Disease
Avoidance of alcohol and sedativesAdjunctive measure when these exposures may worsen pharyngeal collapse. jaccSleep Apnea and Cardiovascular DiseaseReview medication necessity and balance changes against psychiatric, pain, or withdrawal risks. jaccSleep Apnea and Cardiovascular Disease

Escalation

Use anatomic evaluation to select surgery or hypoglossal nerve stimulation

Procedural therapy is generally considered after inadequate response to, or intolerance of, noninvasive treatment.

Refer patients with persistent clinically consequential OSA despite noninvasive therapy, or with treatment-limiting PAP intolerance, for sleep-surgery evaluation when an anatomic target is plausible. Available surgical approaches include nasal septoplasty, adenotonsillectomy, uvulopalatoplasty, and maxillomandibular advancement; multilevel surgery is used when obstruction or collapse occurs at multiple levels. AHA JournalsObstructive Sleep Apnea and Cardiovascular Disease

Use drug-induced sleep endoscopy and upper-airway assessment to characterize the site and pattern of collapse when planning targeted procedural therapy. Upper-airway collapse on drug-induced sleep endoscopy is relevant to surgical and hypoglossal nerve stimulation selection, and preoperative predictors of hypoglossal nerve stimulation response have been described. BMJConfidential: For Review OnlyBMJ1 / 94 1 May 13th, 2025 2 Dr. Di Wang 3 Clinical Editor, The ... Do not use Mallampati grade alone to choose a procedure; it may suggest anatomy but does not replace sleep-study and endoscopic assessment. BMJConfidential: For Review OnlyBMJ1 / 94 1 May 13th, 2025 2 Dr. Di Wang 3 Clinical Editor, The ...

Consider hypoglossal nerve stimulation as a surgical alternative for selected OSA patients who do not tolerate or respond adequately to other treatment approaches. Selection requires evaluation of upper-airway collapse pattern and individualized discussion of surgical risks, expected efficacy, device management, and alternatives. BMJConfidential: For Review OnlyBMJ1 / 94 1 May 13th, 2025 2 Dr. Di Wang 3 Clinical Editor, The ...AHA JournalsObstructive Sleep Apnea and Cardiovascular Disease

Position nasal surgery appropriately: septoplasty may improve PAP delivery rather than serve as stand-alone curative treatment for OSA. AHA JournalsObstructive Sleep Apnea and Cardiovascular Disease For any airway surgery, counsel that procedures are rarely curative and may be best incorporated into a multimodal plan with objective post-treatment reassessment. AHA JournalsObstructive Sleep Apnea and Cardiovascular Disease

Procedural options for patients with inadequately controlled OSA after noninvasive therapy. BMJConfidential: For Review OnlyBMJ1 / 94 1 May 13th, 2025 2 Dr. Di Wang 3 Clinical Editor, The ...AHA JournalsObstructive Sleep Apnea and Cardiovascular Disease
ApproachSelection principleCounseling point
Nasal septoplastyConsider when nasal obstruction impairs PAP delivery or is a component of multilevel obstruction. AHA JournalsObstructive Sleep Apnea and Cardiovascular DiseaseUsually adjunctive rather than curative for OSA. AHA JournalsObstructive Sleep Apnea and Cardiovascular Disease
Multilevel upper-airway surgeryUse when evaluation identifies multiple levels of obstruction or collapse. AHA JournalsObstructive Sleep Apnea and Cardiovascular DiseasePain and anesthesia-related complications are relevant; objective reassessment is needed because cure is uncommon. AHA JournalsObstructive Sleep Apnea and Cardiovascular Disease
Maxillomandibular advancementConsider as an anatomic surgical option within a specialist-directed airway plan. BMJConfidential: For Review OnlyAHA JournalsObstructive Sleep Apnea and Cardiovascular DiseasePreoperative anatomy affects expected response; do not select solely from bedside airway grading. BMJConfidential: For Review OnlyBMJ1 / 94 1 May 13th, 2025 2 Dr. Di Wang 3 Clinical Editor, The ...
Hypoglossal nerve stimulationConsider for selected patients with inadequate tolerance or response to other therapies after collapse-pattern evaluation. BMJConfidential: For Review OnlyBMJ1 / 94 1 May 13th, 2025 2 Dr. Di Wang 3 Clinical Editor, The ...AHA JournalsObstructive Sleep Apnea and Cardiovascular DiseaseRequires surgical implantation and individualized assessment of expected response. BMJConfidential: For Review OnlyBMJ1 / 94 1 May 13th, 2025 2 Dr. Di Wang 3 Clinical Editor, The ...

Monitoring

Reassess efficacy after every material change in therapy or risk profile

OSA treatment is durable only when symptoms, adherence, and cardiometabolic goals are reviewed longitudinally.

After PAP, oral-appliance titration, weight loss intervention, positional treatment, or surgery, reassess symptoms, functional safety, treatment tolerance, and objective control of sleep-disordered breathing. This is particularly important when a patient reports improved snoring but retains sleepiness, hypertension, or device intolerance. The LancetAdult obstructive sleep apnoeaAHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...AHA JournalsObstructive Sleep Apnea and Cardiovascular DiseaseScienceDirectPrediction of oral appliance treatment outcomes in obstructive sleep apnea: A systematic review - ScienceDirect

Monitor BP separately from OSA symptoms. OSA therapy may improve BP, especially with CPAP in resistant hypertension and with combined CPAP plus weight loss in overweight or obesity, but antihypertensive treatment remains necessary when indicated. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ... If BP remains resistant despite apparent OSA control, evaluate adherence and continue the broader secondary-hypertension and medication assessment.

Revisit treatment choice when body weight changes, a dental appliance causes adverse effects, PAP use declines, a positional strategy fails, or postoperative symptoms persist. OSA management frequently requires combination therapy—such as weight management plus PAP, or nasal intervention to facilitate PAP—rather than a single permanent intervention. NaturePathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome | Signal Transduction and Targeted TherapyAHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...AHA JournalsObstructive Sleep Apnea and Cardiovascular DiseasejaccSleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences

Triggers for OSA treatment reassessment. NaturePathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome | Signal Transduction and Targeted TherapyAHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...AHA JournalsObstructive Sleep Apnea and Cardiovascular DiseasejaccSleep Apnea: Types, Mechanisms, and Clinical Cardiovascular ConsequencesScienceDirectPrediction of oral appliance treatment outcomes in obstructive sleep apnea: A systematic review - ScienceDirect
TriggerInterpretationAction
Persistent sleepiness or functional impairmentMay indicate inadequate OSA control, insufficient PAP exposure, or another cause of symptoms. The LancetAdult obstructive sleep apnoeaAHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...Review objective therapy use and repeat sleep-focused evaluation as clinically indicated. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...
PAP intoleranceTreatable interface, pressure-comfort, nasal, or sleep-schedule barriers may be present. NatureThe association between irregularity in sleep-wake rhythm and CPAP adherence | npj Biological Timing and SleepjaccSleep Apnea: Types, Mechanisms, and Clinical Cardiovascular ConsequencesTroubleshoot PAP; consider a custom mandibular advancement device or procedural evaluation when intolerance persists. acpjournalsManagement of Obstructive Sleep Apnea in AdultsAHA JournalsObstructive Sleep Apnea and Cardiovascular DiseaseScienceDirectPrediction of oral appliance treatment outcomes in obstructive sleep apnea: A systematic review - ScienceDirect
Weight gain or substantial weight lossUpper-airway collapsibility and OSA burden may change with weight. NaturePathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome | Signal Transduction and Targeted TherapyScienceDirectAnatomical determinants of upper airway collapsibility in obstructive sleep apnea: A systematic review and meta-analysis - ScienceDirectReassess the adequacy of the existing treatment plan. NaturePathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome | Signal Transduction and Targeted TherapyAHA JournalsObstructive Sleep Apnea and Cardiovascular Disease
Oral-appliance adverse effectsMyofascial discomfort or excess salivation can limit adherence. AHA JournalsObstructive Sleep Apnea and Cardiovascular DiseaseArrange dental reassessment and adjust the device; verify ongoing treatment response. AHA JournalsObstructive Sleep Apnea and Cardiovascular DiseaseScienceDirectPrediction of oral appliance treatment outcomes in obstructive sleep apnea: A systematic review - ScienceDirect

References

  1. Confidential: For Review Onlywww.bmj.com · www.bmj.com
  2. 1 / 94 1 May 13th, 2025 2 Dr. Di Wang 3 Clinical Editor, The ...www.bmj.com · www.bmj.com
  3. Longer-term impacts of the COVID-19 pandemic on ...bmjopenrespres.bmj.com · bmjopenrespres.bmj.com
  4. Supplementary appendixwww.thelancet.com · www.thelancet.com
  5. Adult obstructive sleep apnoeawww.thelancet.com · www.thelancet.com
  6. Effects of obstructive sleep apnoea risk on postoperative ...bmjopen.bmj.com · bmjopen.bmj.com
  7. Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome | Signal Transduction and Targeted Therapywww.nature.com · www.nature.com
  8. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...www.ahajournals.org · www.ahajournals.org
  9. The association between irregularity in sleep-wake rhythm and CPAP adherence | npj Biological Timing and Sleepwww.nature.com · www.nature.com
  10. Automatic prediction of obstructive sleep apnea in patients with temporomandibular disorder based on multidata and machine learning | Scientific Reportswww.nature.com · www.nature.com
  11. General dental practitioners' knowledge and opinions of ...www.nature.com · www.nature.com
  12. Sleep Apnea and Cardiovascular Disease | Circulationwww.ahajournals.org · www.ahajournals.org
  13. Management of Obstructive Sleep Apnea in Adultswww.acpjournals.org · www.acpjournals.org
  14. Obstructive Sleep Apnea and Cardiovascular Diseasewww.ahajournals.org · www.ahajournals.org
  15. Obstructive Sleep Apnea in Cardiovascular Diseasewww.ahajournals.org · www.ahajournals.org
  16. Treatment of Anemia in Patients With Heart Diseasewww.acpjournals.org · www.acpjournals.org
  17. Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequenceswww.jacc.org · www.jacc.org
  18. Sleep Apnea and Cardiovascular Diseasewww.jacc.org · www.jacc.org
  19. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention ...www.jacc.org · www.jacc.org
  20. Sleep Disordered Breathing and Cardiovascular Disease: JACC State-of-the-Art Reviewwww.jacc.org · www.jacc.org
  21. Prediction of oral appliance treatment outcomes in obstructive sleep apnea: A systematic review - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  22. Continuous positive airway pressure versus mandibular advancement device in the treatment of obstructive sleep apnea: a systematic review and meta-analysis - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  23. Anatomical determinants of upper airway collapsibility in obstructive sleep apnea: A systematic review and meta-analysis - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  24. Cardiovascular effects of oral appliance therapy in obstructive sleep apnea: A systematic review and meta-analysiswww.sciencedirect.com · www.sciencedirect.com